Crotedumab

• CAT Number: I042235
• CAS Number: 1452387-69-7
• Purity: ≥95%

Crotedumab（Cat No.:I042235）is a monoclonal antibody designed to target and inhibit the activity of the C5a receptor (C5aR), a key component of the complement system involved in immune responses and inflammation. Crotedumab works by blocking the binding of C5a, a potent inflammatory mediator, to its receptor, thereby reducing inflammation and immune cell activation. It has been studied for its potential therapeutic benefits in diseases characterized by excessive inflammation, such as autoimmune disorders and inflammatory conditions. Clinical trials are exploring its safety and efficacy, particularly in conditions like rheumatoid arthritis and systemic lupus erythematosus.